12
Participants
Start Date
February 27, 2024
Primary Completion Date
May 27, 2024
Study Completion Date
May 27, 2024
Tafamidis 61 mg free acid tablet (Test 1)
Tafamidis 61 mg free acid tablet (Test 1)
Tafamidis 70 mg free acid tablet (Test 1)
Tafamidis 61 mg free acid tablet (Test 1)
Tafamidis 61 mg free acid capsule (Reference)
Tafamidis 61 mg free acid capsule (Reference)
Pfizer Clinical Research Unit - Brussels, Brussels
Lead Sponsor
Pfizer
INDUSTRY